Abstract
In this last decade of the twentieth century we inhabit a world of molecules which are being investigated for the first time at the atomic level, while biologists have begun to manipulate them to our advantage. The current scientific literature abounds with descriptions of transgenic animals, of chimaeric viruses, of viral proteins and enzymes analysed by X-ray crystallography, synthetic genes and, most recently, the ability of biologists to manipulate genes even to a point of fusion of the sperm and ovum.
Chapter PDF
Similar content being viewed by others
Keywords
- Influenza Virus
- Respiratory Syncytial Virus
- Minimum Inhibitory Concen
- Respiratory Syncytial Virus Infection
- Respiratory Virus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Al-Nakib, W., Higgins, P.G., Barrow, G.I., Tyrrell, D.A.J., Andries, K., Vanden Bussche, G. Taylor, N. and Janssen, P.A.J. (1989) Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837) Antimicrob Agents Chemother., 33,522-5.
Al-Nakib, W.. Higgins, P.G., Barrow, I., Tyrrell D.A.J., Lenox-Smith I. and Ishitsuka, H. (1987) Intranasal chalcone Ro 09-0410 as prophylaxis against rhinovirus infection in human volunteers. J. Antimicrob. Chemother., 20, 887 - 92.
Al-Nakib, W., Willman, J., Higgins, P.G., Tyrrell, D.A.J., Shepherd, W.M. and Freestone, D.S. (1987) Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man. Arch. Virol, 92, 255 - 60.
Andries, K., Dewindt, B., Brabander, M., Stokbroekx, R. and Janssen, P.A.J. (1988) In vitro activity of R61837, a new antirhinovirus compound. Arch. Virol, 101, 155 - 67.
Arden, N.H., Patriarca, P.A., Fasano, M.B., Lui, K.J., Harmon, M.W., Kendal. A.P. and Rimland, D. (1988) The roles of vaccination and amantadine prophylaxis in controlling a outbreak of influenza A (H3N2) in a nursing home. Arch. Intern. Med., 148, 865 - 8.
Barrow, G.I., Higgins, P.G., Tyrrell, D.A.J, and Andries, K. (1990) An appraisal of the efficacy of the antiviral R61837 in rhinovirus infections in human volunteers. Antiviral Chemistry and Chemotherapy, 1, 279 - 83.
Beare, A.S. and Reed, S.E. (1977) The study of antiviral compounds in volunteers, in Chemoprophylaxis and Virus Infections of the Respiratory Tract, vol. 2, (ed. J.S. Oxford ), CRC Press, Cleveland, pp. 27 - 55.
Bektimirov, F.A., Douglas, R.G., Dolin, R., Galasso, G.J., Krylov, V.F. and Oxford, J.S. (1985) Current status of amantadine and rimantadine as anti-influenza A agents: memorandum from a WHO meeting. Bull WHO, 63, 51 - 6.
Belshe, R.B., Burk, B., Newman, F., Cerruti, R.L. and Sim, I.S. (1989) Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J. Infect. Dis., 159, 430 - 5.
Brady, M.T., Sears, S.D., Pacini, D.L. et al (1990) Safety and prophylactic efficacy of low dose rimantadine in adults during an influenza A epidemic. Antimicrob. Agents Chemother., 34, 1633 - 6.
Bukrinskaya, A.G., Vorkunova, N.K., Kornilayeva, G.V., Narmanbetova, R.A. and Vorkunova G.K. (1982) Influenza virus uncoat-ing in infected cells and effect of rimantadine. J. Gen. Virol, 60, 49 - 59.
Breese-Hall, C., Dolin, R., Gala, C.L. et al (1987) Children with influenza A infection: treatment with rimantadine. Paediatrics, 80, 275 - 82.
Crawford, S.A., Clover, R.D., Abell, T.D., Ramsey, C.N., Glezen, P. and Couch, R.B. (1988) Rimantadine prophylaxis in children: a follow up study. Paediatr. Infect. Dis., 7, 379 - 83.
Cross, P.A. (1991) Current recommendations for the prevention and treatment of influenza in the older population. Drugs & Ageing, 1, 431 - 9.
Davies, J.R., Grilli, E.A., Smith, A.J. and Hoskins, T.W. (1988) Prophylactic use of amantadine in a boarding school outbreak of influenza A. ]. R. Coll Gen. Pract., 38, 346 - 8.
Davies, W.L., Grunert, R.R., Haff, R.F. et al (1964) Antiviral activity of 1-adamantanamine (amantadine) Science, 144, 862 - 3.
Degelau, J., Somani, S.K., Cooper, S.L., Guay, D.R.P. and Crossley, K.B. (1992) Amantadine resistant influenza A in a nursing facility. Arch. Intern. Med., 152, 390 - 3.
Diana, G.D., Nitz, T.J., Mallamo, J.P. and Treasurywala, A. (1993) Antipicornavirus compounds: use of rational drug design and molecular modelling. Antiviral Chem. Chemother., 4, 1 - 10.
Dimmock, N.J. (1982) Initial stages in infection with animal viruses. ]. Gen. Virol, 59, 1 - 22.
Dolin, R., Reichman, R.C., Madore, H.P., Maynard, R., Linton, P.N., and Webber-Jones, J. (1982) A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N. Engl J. Med., 307, 580.
Dourmashkin, R.R. and Tyrrell, D.A.J. (1974) Electron microscopic observations on the entry of influenza virus into susceptible cells. J. Gen. Virol, 24, 129 - 41.
Fleming, D.M. and Cross, K.W. (1993) Respiratory syncytial virus or influenza? Lancet, 342, 1507 - 10.
Galbraith, A.W., Oxford, J.S., Schild, G.C. and Watson, G.I. (1969) Study of 1-adaman-tanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment. Bull WHO, 41, 677 - 82.
Galbraith, A.W., Oxford, J.S., Schild, G.C. and Watson, G.I. (1969) Protective effect of 1- adamantanamine hydrochloride against influenza A2 in the family environment. Lancet, ii, 1026.
Galbraith, A.W., Oxford, J.S., Schild, G.C. and Watson G.I. (1970) Protective effect of aminoadamantane on influenza A2 infections in the family environment. Ann. N.Y. Acad. Sci., 173, 29 - 43.
HaH, C.B., Dolin, R., Gala, C.L. et al (1987) Children with influenza A infection: treatment with rimantadine. Pediatrics, 80, 275 - 82.
Hay, A.J., Kennedy, N.C., Skehel, J.J. and Appleyard, G. (1979) The matrix protein gene determines amantadine-sensitivity of influenza viruses. J. Gen. Virol, 42, 189 - 91.
Hayden, F.G. and Gwaltney, J.M. Jr ( 1982 ) Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infections. Antimicrob. Agents Chemother., 21, 892 - 7.
Hayden, F.G. and Hay, A.J. (1992) Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr. Topics Microbiol Immunol, 176, 119 - 30.
Hayden, F.G. and Monto, A.S. (1986) Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults. Antimicrob. Agents Chemother., 29, 339 - 41.
Hayden, F.G., Belshe, R.B., Clover, R.D., Hay, A.J., Oakes, M.G. and Soo, W. (1989) Emergence and apparent transmission of rimantadine resistant influenza A virus in famines. N. Engl J. Med., 321, 1696 - 702.
Hayden, F.G., Sperber, S.J., Belshe, R.B., Clover, R.D., Hay, A.J. and Pyke, S. (1991) Recovery of drug resistant influenza A virus during therapeutic use of rimantadine. Antimicrob. Agents Chemother, 35, 1741 - 7.
Heider, H., Adamczyk, B., Presber, H.W., Schroeder, C., Feldblum, R. and Indulen, M.K. (1981) Occurrence of amantadine and rimantadine resistant influenza A virus strains during the 1980 epidemic. Acta Virologica, 25, 395 - 400.
Higgins, P.G., Barrow, G.I., Tyrrell, D.A.J., Isaacs, D. and Gauci, C.L. (1990) The efficacy of intranasal interferon a-2A in respiratory syncytial virus infection in volunteers. Antiviral Res.. 14, 3 - 10.
Higgins, P.G., Barrow, G.I., Tyrrell, D.A.J., Snell, N.J.C., Jones, K. and Jolley, W.B. (1991) A study of the efficacy of the immunomodulatory compound 7-thia-8-oxoguanosine in Coronavirus 229E infections in human volunteers. Antiviral Chem. Chemother., 2, 61 - 3.
Higgins, P.G., Phillpotts, R.J., Scott, G.M., Wallace, J., Bernhardt, L.L. and Tyrrell, D.A.J. (1983) Intranasal interferon as protection against experimental respiratory Coronavirus infection in volunteers. Antimicrob. Agents Chemother., 24, 713 - 15.
Hope-Simpson, E. (1993) The Origin of Epidemic Influenza, Plenum Press, New York.
Kubar, O.I., Brjantseva, E.A., Nikitina, L.E. and Zlydnikov, D.M. (1989) The importance of virus drug resistance in the treatment of influenza with rimantadine. Antiviral Res., 11, 313 - 16.
Levantis, P. and Oxford, J.S. (1992) Molecular aspects of AZT resistance in HIV-I. Res. Virol, 143, 136 - 42.
Lübeck, M.D., Schulman, J.L. and Palese, P. (1978) Susceptibility of influenza A virus to amantadine is influenced by the gene coding for M protein. J. Virol, 28, 710 - 16.
Mast, E.E., Harmon, M.W., Gravenstein, I. et al (1991) Emergence and possible transmission of amantadine resistant viruses during nursing home outbreaks of influenza A (H3N2). Am. J. Epidemiol, 134, 988 - 97.
Merrigan, T.C., Reed, S.E., Hall, T.S. and Tyrrell, D.A.J. (1973) Inhibition of respiratory virus infection by locally applied interferon. Lancet, i, 563-7.
Monto, A.S. and Arden, N.H. (1992) Implications of viral resistance to amantadine in control of influenza A. Clin. Infect. Dis. 15, 362 - 7.
Muckenthaler, M., Gunkel. N., Levantis, P. et al. (1992) Sequence analysis of an HIV-I isolate which displays unusually high-level AZT resistance in vitro. J. Med. Virol., 36, 79 - 83.
Nicholson, K.G. and Wiselka, M.J. (1991) Amantadine for influenza A. Br. Med. J., 302, 425 - 6.
Oxford, J.S., Zuckerman, M.A., Race, E., Dourmashkin, R., Broadhurst, K. and Sutton, P.M. (1994) Sodium deoxycholate exerts a direct destructive effect on HIV and influenza viruses in vitro and inhibits retrovirus induced pathology in an animal model. Antiviral. Chem. Chemother., 5, 176 - 181.
Oxford, J.S. and Galbraith, A. (1980) Antiviral activity of amantadine: a review of laboratory and clinical data. Pharmacol. Ther., 11, 181 - 262.
Oxford, J.S. and Oberg, B. (1985) Conquest of Viral Diseases, Elsevier Biomedical Press, Amsterdam.
Oxford, J.S. and Potter, C.W. (1973) Amino adamantine resistance strains of influenza A2 virus. J. Hygiene., 71, 227 - 35.
Oxford, J.S., Field, H.J. and Reeves, D.S. (eds) (1986) Drug Resistance in Viruses, other Microbes and Eukaryotes, Academic Press, London.
Oxford, J.S., Logan, I.S. and Potter, C.W. (1970) In vivo selection of an influenza A2 strain resistant to amantadine. Nature, 226, 82 - 3.
Patriarca, P.A., Kater, N.A., Kendal, A.P., Bregman, D.J., Smith, J.D. and Sikes, R.K. (1984) Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob. Agents Chemother., 26, 101 - 3.
Philipotts, R.J., DeLong, D.C., Wallace, J., Jones, R.W., Reed, S.E. and Tyrrell, D.A.J. (1981) The activity of enviroxime against rhinovirus infection in man. Lancet, i, 1342-4.
Phillpotts, R.J., Higgins, P.G., Willman, J.S. et al. (1984) Intranasal lymphoblastoid interferon (‘Wellferon’) prophylaxis against rhinovirus and influenza virus in volunteers. J. Interferon Res., 4, 535 - 41.
Phillpotts, R.J., Higgins, P.G., Willman, J.S., Tyrrell, D.A.J, and Lenox-Smith, I. (1984) Evaluation of the antirhinovirus chalcone Ro 09-0415 given orally to volunteers. J. Antimicrob. Chemother., 14, 403 - 9.
Phillpotts, R.J., Wallace, J., Tyrrell, D.A.J., Freestone, D.S. and Shepherd, W.M. ( 1983 ) Failure of oral 4', 6-dichloroflavan to protect against rhinovirus infection in man. Arch. Virol. 75, 115 - 21.
Pinto, L.H., Holsinger, L.J. and Lamb, R.A. (1992) Influenza virus M2 protein has ion channel activity. Cell, 69, 517 - 28.
Reuman, P.D., Bernstein, D.I., Keefer, M.C., Young, E.C., Sherwood, J.R. and Schiff, G.M. (1989) Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza. Antiviral Res., 11, 27 - 40.
Schild, G.C. and Sutton, R.N.P. (1965) Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride. Br. J. Exp. Pathol., 46, 263 - 73.
Scott, G.M., Phillpotts, R.J., Wallace, J., Secher, D.S., Cantell, K. and Tyrrell, D.A.J. (1982) Purified interferon as protection against rhinovirus infection. Br. Med.J., 284, 1822 - 5.
Scott, G.M., Reed, S., Cartwright, T. and Tyrrell, D.A.J. (1980) Failure of human fibroblast interferon to protect against rhinovirus infection. Arch. Virol., 65, 135 - 9.
Scott, G.M., Wallace, J., Greiner, J., Phillpotts, R.J., Gauci, C.L. and Tyrrell, D.A.J. (1982) Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet, i, 186 - 8.
Sears, S.D. and Clements, M.L. (1987) Protective efficacy of low dose amantadine in adults challenged with wild type influenza A virus. Antimicrob. Agents Chemother., 31, 1470 - 3.
Smith, T.J., Kremer, H.J., Luo, M. et al. ( 1986) The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science, 233, 1286 - 93.
Stanley, E.D., Muldoon, R.E., Akers, L.W. and Jackson, G.G. (1965) Evaluation of antiviral drugs: the effect of amantadine on influenza volunteers. Ann. N.Y. Acad. Sei., 130, 44 - 51.
Stuart-Harris, C.H., Schild, G.C. and Oxford, J.S. (1985) Influenza: the Viruses and the Disease, Edward Arnold, London.
Togo, Y., Hornick, R.B. and Dawkins, A.T. (1968) Studies on induced influenza in man. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against A2/Rockville/l/65 strain. JAMA, 203, 1089 - 91.
Tyrrell, D.A.J, and Al-Nakib, W. (1988) Prophylaxis and treatment of rhinovirus infections, in Clinical Use of Antiviral Drugs, (ed. E.De Clercq ), Martinus Nijhoff Publishing, The Hague, pp. 241 - 76.
Tyrrell, D.A.J, and Oxford, J.S. (1985) Antiviral chemotherapy and interferon. Br. Med. Bull., 41, 307 - 405.
Van Voris, L.P., Betts, R.F., Hayden, F.G., Christmas, W.A. and Douglas, R.G. (1981) Successful treatment of naturally occurring influenza A (USSR/77 [H1N1]) JAMA, 245, 1128 - 31.
Van Voris, L.P. and Newell, P.M. (1992) Antivirals for the chemoprophylaxis and treatment of influenza. Setnin. Respir. Infect., 7, 61 - 70.
Von Itzstein, M., Wu, W.Y., Kok, G.B. et al. (1993) Nature, 363, 418 - 23.
Yasin, S.R., Al-Nakib, W. and Tyrrell, D.A.J. (1990) Isolation and preliminary characterisation of chalcone Ro 09-041 0-resistant human rhinovirus type 2. Antiviral Chem. Chemother., 1, 149 - 54.
Zhang, A., Nanni, R.G., Li, T. et al (1993) Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14. ]. Mol. Biol, 230, 857 - 67.
Zerial, A., Werner. G.H., Phillpotts, R.J., Willman, J.S., Higgins, P.G. and Tyrrell, D.A.J. (1985) Studies on 44 081 R.P., a new antirhi-novirus compound, in cell cultures and in volunteers. Antimicrob. Agents Chemother., 27, 846 - 50.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Chapman & Hall
About this chapter
Cite this chapter
Oxford, J., Al-Jabri, A. (1996). Specific Antiviral Therapy of Respiratory Viruses. In: Myint, S., Taylor-Robinson, D. (eds) Viral and Other Infections of the Human Respiratory Tract. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7930-0_21
Download citation
DOI: https://doi.org/10.1007/978-94-011-7930-0_21
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7932-4
Online ISBN: 978-94-011-7930-0
eBook Packages: Springer Book Archive